{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T18:53:51Z","timestamp":1772996031010,"version":"3.50.1"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T00:00:00Z","timestamp":1380844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0075585","type":"journal-article","created":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T21:20:20Z","timestamp":1380921620000},"page":"e75585","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["Comparison of Cryptococcal Antigenemia between Antiretroviral Na\u00efve and Antiretroviral Experienced HIV Positive Patients at Two Hospitals in Ethiopia"],"prefix":"10.1371","volume":"8","author":[{"given":"Tafese","family":"Beyene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimtubezinash","family":"Woldeamanuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Asrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonfa","family":"Ayana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Boulware","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,10,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"BJ Park","year":"2009","journal-title":"AIDS"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-135-1-200107030-00005","article-title":"Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease","volume":"135","author":"CA Murphy EL","year":"2001","journal-title":"Ann Intn Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2334-10-67","article-title":"Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases","volume":"10","author":"JN Jarvis","year":"2010","journal-title":"BMC infectious diseases"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Durski KN, Kuntz KM, Yasukawa K, Virnig BA, Meya DB, <etal>et al<\/etal>.. (2013) Cost-effective diagnostic checklists for meningitis in resource limited settings. J Acquir Immune Defic Syndr 61: <italic>In Press<\/italic>.","DOI":"10.1097\/QAI.0b013e31828e1e56"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-3156.2010.02565.x","article-title":"Diagnosis of cryptococcal and tuberculous meningitis in a resource-limited African setting","volume":"15","author":"DB Cohen","year":"2010","journal-title":"Trop Med Int Health"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/00002030-200007070-00013","article-title":"Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients","volume":"14","author":"JG Hakim","year":"2000","journal-title":"AIDS"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7196\/SAMJ.4795","article-title":"Cryptococcal meningitis\u2013a neglected killer","volume":"101","author":"J Jarvis","year":"2011","journal-title":"S Afr Med J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1097\/QAI.0b013e31824c837e","article-title":"Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care","volume":"59","author":"R Rajasingham","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jinf.2010.03.015","article-title":"The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts","volume":"60","author":"P Pongsai","year":"2010","journal-title":"J Infect"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/655143","article-title":"Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count&lt;or = 100 cells\/microL who start HIV therapy in resource-limited settings","volume":"51","author":"DB Meya","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/00002030-200205030-00009","article-title":"Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults","volume":"16","author":"N French","year":"2002","journal-title":"AIDS"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1086\/597262","article-title":"Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa","volume":"48","author":"JN Jarvis","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-3156.2007.01874.x","article-title":"Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda","volume":"12","author":"CA Liechty","year":"2007","journal-title":"Trop Med Int Health"},{"key":"ref14","unstructured":"WHO (2011) Rapid advice: Diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children. Geneva: World Health Organization.Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/pub\/cryptococcal_disease2011\" xlink:type=\"simple\">www.who.int\/hiv\/pub\/cryptococcal_disease2011<\/ext-link> Accessed: May 31, 2012."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7196\/SAMJ.4752","article-title":"Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts\u2013time to implement in South Africa?","volume":"101","author":"JN Jarvis","year":"2011","journal-title":"S Afr Med J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S1473-3099(11)70245-6","article-title":"Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial","volume":"11","author":"R Parkes-Ratanshi","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e13856","DOI":"10.1371\/journal.pone.0013856","article-title":"Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia","volume":"5","author":"R Micol","year":"2010","journal-title":"PloS one"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/QAI.0b013e31811ed32c","article-title":"Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients","volume":"45","author":"R Micol","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00126334-200307010-00019","article-title":"Systematic screening of cryptococcal antigenemia in HIV-positive adults in Uganda","volume":"33","author":"JM Tassie","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1758-2652-15-15","article-title":"Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study","volume":"15","author":"J Oyella","year":"2012","journal-title":"J Int AIDS Soc"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-3156.2010.02683.x","article-title":"Short Communication: Low seroprevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme in Ghana","volume":"16","author":"SS Mamoojee Y","year":"2011","journal-title":"Trop Med Int Health"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1758-2652-14-48","article-title":"Universal screening of Tanzanian HIV-infected adult inpatients with the serum cryptococcal antigen to improve diagnosis and reduce mortality: an operational study","volume":"14","author":"BM Wajanga","year":"2011","journal-title":"J Int AIDS Soc"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00002030-198902000-00004","article-title":"The value of cryptococcal serum antigen screening among HIV-positive\/AIDS patients in Kinshasa, Zaire","volume":"3","author":"P Desmet","year":"1989","journal-title":"AIDS"},{"key":"ref24","first-page":"344","article-title":"Cryptococcal antigenemia in anti-retroviral naive AIDS patients: prevalence and its association with CD4 cell count","volume":"50","author":"OF Osazuwa","year":"2012","journal-title":"Acta Med Iran"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1093\/cid\/cir903","article-title":"High prevalence of cryptococcal infection among HIV-infected patients hospitalized with pneumonia in Thailand","volume":"54","author":"JR Harris","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e58377","DOI":"10.1371\/journal.pone.0058377","article-title":"High prevalence of cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia","volume":"8","author":"AS Alemu","year":"2013","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e62213","DOI":"10.1371\/journal.pone.0062213","article-title":"Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program - Vietnam","volume":"8","author":"RM Smith","year":"2013","journal-title":"PLoS One"},{"key":"ref28","unstructured":"Ryan KJ, Ray CG, editors (2004) Sheris Medical Microbiolgy An Introduction of Infection Diseases. 4th ed: Mcgraw-Hill. 669\u2013672 p."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e1001316","DOI":"10.1371\/journal.pmed.1001316","article-title":"Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis","volume":"9","author":"R Rajasingham","year":"2012","journal-title":"PLoS Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/cid\/cis725","article-title":"Reconsidering cryptococcal antigen screening in the U.S. among persons with CD4&lt;100 cells\/mcL","volume":"55","author":"R Rajasingham","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e51291","DOI":"10.1371\/journal.pone.0051291","article-title":"Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda","volume":"7","author":"EK Butler","year":"2012","journal-title":"PLoS One"},{"key":"ref32","first-page":"237","article-title":"Cryptococcal meningitis in patients with acquired immunudeficiency syndrome in prehaart era at Gondar College of Medical Sciences Hospital north-west Ethiopia","volume":"48","author":"T Seboxa","year":"2010","journal-title":"Ethiop Med J"},{"key":"ref33","first-page":"185","article-title":"Cryptococcosis in patients from Tikur Anbessa Hospital, Addis Ababa, Ethiopia","volume":"39","author":"Y Woldemanuel","year":"2001","journal-title":"Ethiop Med J"},{"key":"ref34","unstructured":"PEPFAR (2013) The President\u2018s Emergency Plan for AIDS Relief: FY 2013 Technical Considerations. Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.pepfar.gov\/documents\/organization\/199147.pdf\" xlink:type=\"simple\">www.pepfar.gov\/documents\/organization\/199147.pdf<\/ext-link>. Accessed July 26, 2013."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/1545109712459077","article-title":"Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation","volume":"11","author":"JN Jarvis","year":"2012","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-6405-7-29","article-title":"Utility of clinical assessment, imaging, and cryptococcal antigen titer to predict AIDS-related complicated forms of cryptococcal meningitis","volume":"7","author":"ER Cachay","year":"2010","journal-title":"AIDS Res Ther"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijid.2007.01.014","article-title":"The medical management of central nervous system infections in Uganda and the potential impact of an algorithm-based approach to improve outcomes","volume":"11","author":"JD Trachtenberg","year":"2007","journal-title":"Int J Infect Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/QAD.0b013e3283383aeb","article-title":"Testing but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme","volume":"24","author":"JN Jarvis","year":"2010","journal-title":"AIDS"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2334-7-39","article-title":"Low CD4 count plus coma predicts cryptococcal meningitis in Tanzania","volume":"7","author":"PR Kisenge","year":"2007","journal-title":"BMC Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1758-2652-14-48","article-title":"Universal screening of Tanzanian HIV-infected adult inpatients with the serum cryptococcal antigen to improve diagnosis and reduce mortality: an operational study","volume":"14","author":"BM Wajanga","year":"2011","journal-title":"J Int AIDS Soc"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1758-2652-12-21","article-title":"Clinical presentation and aetiologies of acute or complicated headache among HIV-seropositive patients in a Ugandan clinic","volume":"12","author":"M Katwere","year":"2009","journal-title":"J Int AIDS Soc"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.3402\/gha.v3i0.5398","article-title":"Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia","volume":"3","author":"AW Alemu","year":"2010","journal-title":"Glob Health Action"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/587667","article-title":"Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy","volume":"46","author":"A Kambugu","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/588792","article-title":"High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial","volume":"47","author":"T Bicanic","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1086\/338154","article-title":"A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand","volume":"34","author":"SK Chariyalertsak S","year":"2002","journal-title":"Clin Infect Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1097\/QAD.0b013e32832be0fc","article-title":"High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out","volume":"23","author":"JN Jarvis","year":"2009","journal-title":"AIDS"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/cid\/cir613","article-title":"Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis","volume":"53","author":"JN Jarvis","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref48","unstructured":"Rolfes MAR, Butler E, von Hohenberg M, Bahr N, Musubire A, <etal>et al<\/etal>.. (2012) Evaluation of a novel point-of-care lateral flow assay to detect cryptococcal antigen in plasma and CSF. Abstract 953. CROI. Seattle."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0075585","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:25:38Z","timestamp":1588965938000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0075585"}},"subtitle":[],"editor":[{"given":"Shamala Devi","family":"Sekaran","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,4]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0075585","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,4]]}}}